Post-pandemic Era-Global Active Pharmaceutical Ingredients (API) Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin

Report ID: 247666 | Published Date: Jan 2025 | No. of Page: 101 | Base Year: 2024 | Rating: 4.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
Table of Contents

Global Active Pharmaceutical Ingredients (API) Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
1 Market Scope
    1.1 Product Details and Introduction
      1.1.1 CNS -Product Introduction and Major Manufacturers
      1.1.2 Cardiovascular -Product Introduction and Major Manufacturers
      1.1.3 Genitourinary/Hormonal Drugs -Product Introduction and Major Manufacturers
      1.1.4 Respiratory -Product Introduction and Major Manufacturers
      1.1.5 Rheumatology -Product Introduction and Major Manufacturers
      1.1.6 Diabetes -Product Introduction and Major Manufacturers
      1.1.7 Oncology -Product Introduction and Major Manufacturers
      1.1.8 Others -Product Introduction and Major Manufacturers
    1.2 Market Snapshot
      1.2.1 Major Companies Overview
      1.2.2 Market Concentration
      1.2.3 Six-Year Compound Annual Growth Rate (CAGR)
2 Regional Market Analysis
    2.1 China Active Pharmaceutical Ingredients (API) Status and Prospect (2015-2026)
      2.1.1 China Active Pharmaceutical Ingredients (API) Market Size and Growth Rate (2015-2026)
      2.1.2 China Active Pharmaceutical Ingredients (API) Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
    2.2 EU Active Pharmaceutical Ingredients (API) Status and Prospect (2015-2026)
      2.2.1 EU Active Pharmaceutical Ingredients (API) Market Size and Growth Rate (2015-2026)
      2.2.2 EU Active Pharmaceutical Ingredients (API) Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
    2.3 USA Active Pharmaceutical Ingredients (API) Status and Prospect (2015-2026)
      2.3.1 USA Active Pharmaceutical Ingredients (API) Market Size and Growth Rate (2015-2026)
      2.3.2 USA Active Pharmaceutical Ingredients (API) Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
    2.4 Japan Active Pharmaceutical Ingredients (API) Status and Prospect (2015-2026)
      2.4.1 Japan Active Pharmaceutical Ingredients (API) Market Size and Growth Rate (2015-2026)
      2.4.2 Japan Active Pharmaceutical Ingredients (API) Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
    2.5 India Active Pharmaceutical Ingredients (API) Status and Prospect (2015-2026)
      2.5.1 India Active Pharmaceutical Ingredients (API) Market Size and Growth Rate (2015-2026)
      2.5.2 India Active Pharmaceutical Ingredients (API) Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
    2.6 Southeast Asia Active Pharmaceutical Ingredients (API) Status and Prospect (2015-2026)
      2.6.1 Southeast Asia Active Pharmaceutical Ingredients (API) Market Size and Growth Rate (2015-2026)
      2.6.2 Southeast Asia Active Pharmaceutical Ingredients (API) Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
    2.7 South America Active Pharmaceutical Ingredients (API) Status and Prospect (2015-2026)
      2.7.1 South America Active Pharmaceutical Ingredients (API) Market Size and Growth Rate (2015-2026)
      2.7.2 South America Active Pharmaceutical Ingredients (API) Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
    2.8  Active Pharmaceutical Ingredients (API) Status and Prospect (2015-2026)
      2.8.1  Active Pharmaceutical Ingredients (API) Market Size and Growth Rate (2015-2026)
      2.8.2  Active Pharmaceutical Ingredients (API) Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
3 Global Active Pharmaceutical Ingredients (API) Market Assessment by Segment
    3.1 Global Active Pharmaceutical Ingredients (API) Capacity and Growth Rate
    3.2 Global Active Pharmaceutical Ingredients (API) Sales by Type
    3.3 Global Active Pharmaceutical Ingredients (API) Sales Revenue by Type
    3.4 Global Active Pharmaceutical Ingredients (API) Consumption by Application
4 Global Active Pharmaceutical Ingredients (API) Market Assessment by Regions
    4.1 Global Active Pharmaceutical Ingredients (API) Production Analysis and Forecast by Regions (2015-2026)
    4.2 Global Active Pharmaceutical Ingredients (API) Sales Analysis and Forecast by Regions (2015-2026)
    4.3 Global Active Pharmaceutical Ingredients (API) Sales Revenue Analysis and Forecast by Regions (2015-2026)
5 Value Chain (Impact of COVID-19)
    5.1 Active Pharmaceutical Ingredients (API) Value Chain Analysis
      5.1.1 Upstream
      5.1.2 Downstream
    5.2 COVID-19 Impact on Active Pharmaceutical Ingredients (API) Industry
      5.2.1 Industrial Policy Issued Under the Epidemic Situation
    5.3 Cost-Under the Epidemic Situation
      5.3.1 Cost of Raw Material
    5.4 Channel Analysis
      5.4.1 Distribution Channel-Under the Epidemic Situation
      5.4.2 Distributors
6 Competitive Landscape
    6.1 Global Active Pharmaceutical Ingredients (API) Capacity Market Share of Manufacturers (2019-2020)
    6.2 Global Active Pharmaceutical Ingredients (API) Sales Market Share of Manufacturers (2019-2020)
    6.3 Global Active Pharmaceutical Ingredients (API) Sales Revenue Market Share of Manufacturers (2019-2020)

7 Active Pharmaceutical Ingredients (API) Competitive Analysis
     7.1 SGS South Africa
        7.1.1 SGS South Africa Company Profiles
        7.1.2 SGS South Africa Product Introduction
        7.1.3 SGS South Africa Active Pharmaceutical Ingredients (API) Production, Revenue (2015-2020)
        7.1.4 SWOT Analysis
     7.2 Ketlaphela Pharmaceutical
        7.2.1 Ketlaphela Pharmaceutical Company Profiles
        7.2.2 Ketlaphela Pharmaceutical Product Introduction
        7.2.3 Ketlaphela Pharmaceutical Active Pharmaceutical Ingredients (API) Production, Revenue (2015-2020)
        7.2.4 SWOT Analysis
     7.3 Yokogawa South Africa
        7.3.1 Yokogawa South Africa Company Profiles
        7.3.2 Yokogawa South Africa Product Introduction
        7.3.3 Yokogawa South Africa Active Pharmaceutical Ingredients (API) Production, Revenue (2015-2020)
        7.3.4 SWOT Analysis
     7.4 Aurobindo pharma
        7.4.1 Aurobindo pharma Company Profiles
        7.4.2 Aurobindo pharma Product Introduction
        7.4.3 Aurobindo pharma Active Pharmaceutical Ingredients (API) Production, Revenue (2015-2020)
        7.4.4 SWOT Analysis
     7.5 Cipla
        7.5.1 Cipla Company Profiles
        7.5.2 Cipla Product Introduction
        7.5.3 Cipla Active Pharmaceutical Ingredients (API) Production, Revenue (2015-2020)
        7.5.4 SWOT Analysis
     7.6 Haerbin Pharmaceutical
        7.6.1 Haerbin Pharmaceutical Company Profiles
        7.6.2 Haerbin Pharmaceutical Product Introduction
        7.6.3 Haerbin Pharmaceutical Active Pharmaceutical Ingredients (API) Production, Revenue (2015-2020)
        7.6.4 SWOT Analysis
     7.7 Lupin
        7.7.1 Lupin Company Profiles
        7.7.2 Lupin Product Introduction
        7.7.3 Lupin Active Pharmaceutical Ingredients (API) Production, Revenue (2015-2020)
        7.7.4 SWOT Analysis
     7.8 Bachem
        7.8.1 Bachem Company Profiles
        7.8.2 Bachem Product Introduction
        7.8.3 Bachem Active Pharmaceutical Ingredients (API) Production, Revenue (2015-2020)
        7.8.4 SWOT Analysis
8 Conclusion



List of Tables and Figures

    Figure Product Introduction
    Table Production (K Units) and Revenue (Million USD) of Major Players (2015-2020)
    Figure Global Active Pharmaceutical Ingredients (API) Production Market Share of Top 5 Players
    Table CAGR of Major Market (2021-2026)
    Table CAGR in Terms of Production of Each Type (2015-2026)
    Table CAGR in Terms of Production of Each Application (2015-2026)
    Table Global Active Pharmaceutical Ingredients (API) Sales (K Unit) by Type (2015-2026)
    Figure Global Active Pharmaceutical Ingredients (API) Sales (K Unit) and Growth Rate (2015-2026)
    Figure Global Active Pharmaceutical Ingredients (API) Sales Market Share (%) by Type (2019 -2020)
    Table Global Active Pharmaceutical Ingredients (API) Sales Value (Million USD) by Type (2015-2026)
    Figure Global Active Pharmaceutical Ingredients (API) Sales Value (Million USD) and Growth Rate (2015-2026)
    Figure Global Active Pharmaceutical Ingredients (API) Sales Value Market Share (%) by Type (2019-2020)
    Table Global Active Pharmaceutical Ingredients (API) Sales (K Unit) by Application (2015-2026)
    Figure China Active Pharmaceutical Ingredients (API) Production Value (Million USD) and Growth Rate (2015-2026)
    Table China Active Pharmaceutical Ingredients (API) Local Capacity, Import, Export and Local Consumption (2015-2020)
    Figure EU Active Pharmaceutical Ingredients (API) Production Value (Million USD) and Growth Rate (2015-2026)
    Table EU Active Pharmaceutical Ingredients (API) Local Capacity, Import, Export and Local Consumption (2015-2020)
    Figure North America Active Pharmaceutical Ingredients (API) Production Value (Million USD) and Growth Rate (2015-2026)
    Table North America Active Pharmaceutical Ingredients (API) Local Capacity, Import, Export and Local Consumption (2015-2020)
    Figure Japan Active Pharmaceutical Ingredients (API) Production Value (Million USD) and Growth Rate (2015-2026)
    Table Japan Active Pharmaceutical Ingredients (API) Local Capacity, Import, Export and Local Consumption (2015-2020)
    Figure India Active Pharmaceutical Ingredients (API) Production Value (Million USD) and Growth Rate (2015-2026)
    Table India Active Pharmaceutical Ingredients (API) Local Capacity, Import, Export and Local Consumption (2015-2020)
    Figure Southeast Asia Active Pharmaceutical Ingredients (API) Production Value (Million USD) and Growth Rate (2015-2026)
    Table Southeast Asia Active Pharmaceutical Ingredients (API) Local Capacity, Import, Export and Local Consumption (2015-2020)
    Figure South America Active Pharmaceutical Ingredients (API) Production Value (Million USD) and Growth Rate (2015-2026)
    Table South America Active Pharmaceutical Ingredients (API) Local Capacity, Import, Export and Local Consumption (2015-2020)
    Figure Middle East and Africa Active Pharmaceutical Ingredients (API) Production Value (Million USD) and Growth Rate (2015-2026)
    Table Middle East and Africa Active Pharmaceutical Ingredients (API) Local Capacity, Import, Export and Local Consumption (2015-2020)
    Table Global Active Pharmaceutical Ingredients (API) Capacity (K Units) and Growth Rate (2015-2026)
    Figure Global Active Pharmaceutical Ingredients (API) Capacity (K Units) and Growth Rate (2015-2026)
    Table Global Active Pharmaceutical Ingredients (API) Sales (Unit) by Type (2015-2026)
    Figure Global Active Pharmaceutical Ingredients (API) Sales(Unit) and Growth Rate (2015-2026)
    Table Sales Market Share (%) by Type (2019-2026)
    Table Global Active Pharmaceutical Ingredients (API) Sales Revenue (Million USD) by Type (2015-2026)
    Figure Global Active Pharmaceutical Ingredients (API) Sales Revenue (Million USD) and Growth Rate (2015-2026)
    Table Sales Revenue Market Share (%) by Type (2019-2026)
    Table Global Active Pharmaceutical Ingredients (API) Consumption (Unit) by Application (2015-2026)
    Figure Global Active Pharmaceutical Ingredients (API) Consumption (Unit) and Growth Rate (2015-2026)
    Table Consumption Market Share (%) by Application (2019-2026)
    Table Global Active Pharmaceutical Ingredients (API) Production (K Unite) by Regions (2015-2020)
    Table Global Active Pharmaceutical Ingredients (API) CAGR (%) in term of Production and Market Share by Regions (2015-2026)
    Figure Global Active Pharmaceutical Ingredients (API) Production Share by Regions (2019-2020)
    Table Global Active Pharmaceutical Ingredients (API) Sales (K Unite) by Regions (2015-2020)
    Table Global Active Pharmaceutical Ingredients (API) CAGR (%) in term of Sales and Market Share by Regions (2015-2026)
    Figure Global Active Pharmaceutical Ingredients (API) Sales Share by Regions (2019-2020)
    Table Global Active Pharmaceutical Ingredients (API) Sales Revenue (Million USD) by Regions (2015-2020)
    Table Global Active Pharmaceutical Ingredients (API) CAGR (%) in term of Sales Revenue and Market Share by Regions (2015-2026)
    Figure Global Active Pharmaceutical Ingredients (API) Sales Revenue Share by Regions (2019-2020)
    Figure Value Chain Structure of Active Pharmaceutical Ingredients (API)
    Table Value Chain
    Table Key Suppliers of Raw Material/Components
    Table Key Downstream Customer in Each Application Field
    Table Industry News List of Active Pharmaceutical Ingredients (API)
    Figure Cost Structure of Active Pharmaceutical Ingredients (API) in 2020
    Table Global Active Pharmaceutical Ingredients (API) Capacity Share of Manufacturers (2019-2020)
    Figure Global Active Pharmaceutical Ingredients (API) Capacity Share of Manufacturers (2019-2020)
    Table Global Active Pharmaceutical Ingredients (API) Sales Market Share of Manufacturers (2019-2020)
    Figure Global Active Pharmaceutical Ingredients (API) Sales Market Share of Manufacturers (2019-2020)
    Table Global Active Pharmaceutical Ingredients (API) Sales Revenue Market Share of Manufacturers (2019-2020)
    Figure Global Active Pharmaceutical Ingredients (API) Sales Revenue Market Share of Manufacturers (2019-2020)
    Figure Global Active Pharmaceutical Ingredients (API) Sales Value (Million USD), Growth Rate & Market Share (2021-2026)
    Table SGS South Africa Profiles
    Table SGS South Africa Active Pharmaceutical Ingredients (API) Product Introduction
    Table SGS South Africa Active Pharmaceutical Ingredients (API) Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
    Figure SGS South Africa SWOT Analysis
    Table Ketlaphela Pharmaceutical Profiles
    Table Ketlaphela Pharmaceutical Active Pharmaceutical Ingredients (API) Product Introduction
    Table Ketlaphela Pharmaceutical Active Pharmaceutical Ingredients (API) Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
    Figure Ketlaphela Pharmaceutical SWOT Analysis
    Table Yokogawa South Africa Profiles
    Table Yokogawa South Africa Active Pharmaceutical Ingredients (API) Product Introduction
    Table Yokogawa South Africa Active Pharmaceutical Ingredients (API) Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
    Figure Yokogawa South Africa SWOT Analysis
    Table Aurobindo pharma Profiles
    Table Aurobindo pharma Active Pharmaceutical Ingredients (API) Product Introduction
    Table Aurobindo pharma Active Pharmaceutical Ingredients (API) Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
    Figure Aurobindo pharma SWOT Analysis
    Table Cipla Profiles
    Table Cipla Active Pharmaceutical Ingredients (API) Product Introduction
    Table Cipla Active Pharmaceutical Ingredients (API) Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
    Figure Cipla SWOT Analysis
    Table Haerbin Pharmaceutical Profiles
    Table Haerbin Pharmaceutical Active Pharmaceutical Ingredients (API) Product Introduction
    Table Haerbin Pharmaceutical Active Pharmaceutical Ingredients (API) Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
    Figure Haerbin Pharmaceutical SWOT Analysis
    Table Lupin Profiles
    Table Lupin Active Pharmaceutical Ingredients (API) Product Introduction
    Table Lupin Active Pharmaceutical Ingredients (API) Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
    Figure Lupin SWOT Analysis
    Table Bachem Profiles
    Table Bachem Active Pharmaceutical Ingredients (API) Product Introduction
    Table Bachem Active Pharmaceutical Ingredients (API) Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
    Figure Bachem SWOT Analysis
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Post-pandemic Era-Global Active Pharmaceutical Ingredients Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Post-pandemic Era-Global Active Pharmaceutical Ingredients Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Post-pandemic Era-Global Active Pharmaceutical Ingredients Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports